Grants and Contracts Details
Description
Tinnitus is a conscious perception of a sound without real acoustic stimulation, and can be
induced by many factors, such as intense noise and ototoxic drugs. Salicylate (aspirin) is a
well-known ototoxic drug that can cause severe tinnitus and hearing loss. Although the
salicylate can induce alterations of neural activity in the auditory centers, the significant
pathophysiological changes locate in the cochlear outer hair cells (ORCs). A mammalian
OHC has electromotility and piezoelectricity. Salicylate can eliminate OHC electromotility to
induce hearing loss. However, the mechanism of its induced tinnitus remains unclear. Recent
experiments revealed that ORC piezoelectricity could induce lateral inhibition in the cochlea.
We hypothesize that salicylate may also diminishes the OHC piezoelectricity induced lateral
inhibition and results in overactivity of hair cells to generate tinnitus. In this project, the effect
of salicylate on OHC piezoelectricity and lateral inhibition will be recorded using a patch
clamp technique, and the counteraction of chlorpromazine to the salicylate effect will be
tested. These experiments will elucidate the cellular and biophysical mechanisms underlying
the salicylate-induced tinnitus, and will also provide information about the role of OHC
piezoelectricity induced cochlear lateral inhibition in tinnitus generation.
Status | Finished |
---|---|
Effective start/end date | 7/1/04 → 6/30/06 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.